Min Cui, Decheng Capital founder
June 17, 2024 01:48 PM EDT
Financing
Startups

Life sci­ences in­vestor Decheng Cap­i­tal tar­gets $700M for fifth fund

Kyle LaHucik

Senior Reporter

Af­ter $900 mil­lion and $500-plus mil­lion fund clo­sures last week from Fore­site Cap­i­tal and JP Mor­gan, re­spec­tive­ly, an­oth­er firm wants to en­ter the up­per ech­e­lons …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Lyell re­ports pa­tient death, ear­ly re­spons­es in sol­id tu­mor CAR-T tri­al

Alex­is Borisy and Zach Wein­berg's Curie.Bio se­cures $380M to sup­port port­fo­lio's Se­ries A rounds

Zealand rides obe­si­ty wave with $1B raise to ad­vance amylin drug and look for a part­ner

Can CRISPR be giv­en twice? Small study from In­tel­lia sug­gests it can

Ar­row­head shelves one car­diometa­bol­ic drug can­di­date, fo­cus­es on an­oth­er

With a $372M megaround, For­ma­tion Bio looks to in-li­cense 10+ drugs

A service from the Financial Times